- Home
- Companies
- american samoa
- microbiome
Show results for
Refine by
Industries served
- Medical / Health Care
- Agriculture
- Monitoring and Testing
- Environmental
- Water and Wastewater
- University / Academia / Research
- Chemical & Pharmaceuticals
- Health and Safety
- Manufacturing, Other
- Food and Beverage
- Waste and Recycling
- Air and Climate
- Soil and Groundwater
- Government
- Paint
- Pulp & Paper
- Oil, Gas & Refineries
- Energy
Microbiome Suppliers Serving American Samoa
74 companies found
based inGijón, SPAIN
Our mission is to develop novel technologies and next generation live biotherapeutic products providing innovative solutions to health care by harnessing the treasure of the human microbiota. We are developing a novel class biotherapeutic products ...
based inIrvine, CALIFORNIA (USA)
Since 1994, Zymo Research has been led by a vision to have a positive impact in the biomedical field and to contribute to the greater good of humanity. Our innovative sample collection reagents, kits and devices have been used all over the World; ...
based inHollywood, FLORIDA (USA)
Probiotic Indoor Air Purification reduces allergens, bacteria, and mold to improve air quality and create a healthier, cleaner indoor environment. EnviroBiotics rejuvenate and restore indoor spaces, replicating the natural processes refined by ...
based inSeongnam-si, SOUTH KOREA
LISCure Biosciences Provides Novel Therapeutics to Patients with Refractory Diseases Using the LMT Platform. LISCure is developing the world’s first injectable immuno-oncology program using non-pathogenic microorganisms. We focus on the development ...
LMT (LISCure Microbiology-based Technology) Platform Consists of the Therapeutic Screening Platform, Microbial Optimization Platform, and Microbiome Database ...
based inKraków, POLAND
Instytut Biotechnologii Surowic i Szczepionek BIOMED Spółka Akcyjna is a Polish biotechnological company combining modernity with tradition. We manufacture biological medications (biologicals), in particular specific and non-specific bacterial ...
based inOttawa, ONTARIO (CANADA)
Our success is based on our strong relationship with our valued customers, our innovative environment and our passion for quality. DNA Genotek, a subsidiary of OraSure Technologies, Inc., develops products that optimize ease of collection and ...
DNA Genotek understands the importance of streamlined operational workflows and enhancing awareness when conducting large-scale sample collections for human genomic and microbiome research or when offering a commercial service. The ...
based inCambridge, MASSACHUSETTS (USA)
AOBiome has identified significant therapeutic opportunities caused by the adverse impact of the modern environment on human physiology. The human body relies on a system of multiple microorganisms, chemistries, and pathways which have shaped the ...
The human microbiome consists of hundreds of trillions of microorganisms, outnumbering human cells by 10 to 1 with as many as 3 million bacterial genes to our approximately 20 thousand. While the microbiome has ...
based inCambridge, UNITED KINGDOM
Owlstone Medical is developing a breathalyzer for disease. With a goal to find ways to improve non-invasive diagnostics for respiratory diseases, liver diseases, cancer, digestive health and other conditions. Our mission is to save 100,000 lives and ...
based inBoston, MASSACHUSETTS (USA)
Like our customers and their consumers, we needed a real change in the probiotic world that would result in products with benefits we can all feel. We knew current probiotics on the market deliver unpredictable benefits for some people, while not ...
Yso5 is a discovery-stage program leveraging a specific keystone gut bacteria (undisclosed) to potentiate the effects of Immune Checkpoint Blockade (ICB) drugs. The field of cancer therapy has been revolutionized by the use of immunotherapy. The ...
based inMadison, WISCONSIN (USA)
Class Biologically Clean, Ltd. specializes in the production and supply of flexible film isolators and containment units, designed to protect both research and researchers. Catering to the needs of the animal research and biopharmaceutical ...
based inMórahalom Csongrád, HUNGARY
The privately held small enterprise SeqOmics Biotechnology Ltd. was founded by established scientists in order to provide solutions for the permanently increasing demand for genomics and bioinformatics services, as well as food safety and animal ...
based inSomerville, MASSACHUSETTS (USA)
Finch Therapeutics is a clinical-stage microbiome therapeutics company leveraging its Human-First Discovery platform to develop a novel class of orally administered biological drugs. With the capabilities to develop both complete and targeted ...
Our lead product candidate, CP101, is an orally administered, Complete Consortia product candidate initially targeting the prevention of recurrent CDI. The Centers for Disease Control and Prevention considers CDI to be one of the top three most ...
based inHaidian District, CHINA
Beijing Enhalor International Tech Co., Ltd. is born from the Feed Research Institute, Chinese Academy of Agricultural Sciences. The Institute of Enhalor Biotechnology harnesses biology to address diverse critical global challenges in nutrition and ...
based inTralee, IRELAND
BioAtlantis was established in 2004 and entered the crop biostimulant market in 2007 with stress mitigation as a central strategy. Stress is now recognised worldwide as affecting most life forms. It can be split into two main categories, abiotic and ...
based inLake Bluff, ILLINOIS (USA)
Realize Therapeutics is focused on providing Health Care Practitioners (HCPs) with medical nutrition solutions for their patients suffering from obesity and type 2 diabetes. Realize’s strategy is to develop microbe and endocannabinoid formulations ...
Intestinal flora affect blood sugar and heart health by reducing cholesterol levels, blood pressure and inflammation. Realize products based on microbiome restoration and modulation are being developed to treat cardiovascular and ...
based inOslo, NORWAY
Bio-Me is Setting the Standard for Routine Microbiome Analysis. Gut microbiome research has become essential to almost every medical research field. Next-generation sequencing (NGS) technologies have been crucial in enabling a breakthrough in our ...
Our latest ready-to-use microbiome analysis solution. It consists of close to 100 unique assays for specific bacterial and fungal targets, including two controls. Targets were selected after extensive literature and database ...
based inRoseville, MINNESOTA (USA)
Rebiotix Inc., a Ferring Company, is a clinical stage biotechnology company founded to revolutionize the treatment of debilitating diseases by harnessing the power of the human microbiome. The company is on the forefront of an exciting potential ...
The human microbiome is defined as the microbial community (bacteria, fungi, viruses and protozoa) present in the human body. The human microbiome aids in the maintenance and development of the immune system and ...
based inGlasgow, UNITED KINGDOM
We’re a leading microbiome therapeutics company. We have established proprietary MHRA licensed manufacturing capabilities and a supply chain model that enables us to leverage a pipeline of internal and partnered programmes around our lead asset, ...
We’re developing orally administered, high-diversity, high-viability microbiome enhancing medicines for the effective treatment of a broad range of serious diseases and disorders linked to the gut microbiome. ...
based inKennesaw, GEORGIA (US) (USA)
Omni International, Inc, with headquarters in Kennesaw Georgia, is a leading global manufacturer and distributor of laboratory homogenizers. Omni sets the industry standard with an unmatched commitment to outstanding product design, reliable ...
based inBrisbane City, AUSTRALIA
Microba’s precise microbiome analysis is built on the expertise of our innovative team at the leading edge of microbiome science. Our approach to microbiome analysis is enabling new discoveries and advancing the understanding of the microbiome in ...
Developing novel therapeutics from the human microbiome; The uncultured portion of the human gut microbiome, which is the majority of microbial species, represents untapped therapeutic opportunity. Microba has ...
